Stock Comparison

ROIV vs VRTX

Roivant Sciences Ltd and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ROIV

Roivant Sciences Ltd

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$24.51B

$124.70B

P/E (TTM)

—

29.2

Forward P/E

—

25.8

Price/Sales

2,966.8

10.2

Price/Book

5.4

6.4

EV/EBITDA

0.7

24.0

Dividend Yield

—

Profitability

Net Margin

0.00%

35.50%

Operating Margin

-14675.00%

38.10%

Return on Equity

-7.59%

24.20%

Return on Assets

-14.30%

12.10%

Growth (YoY)

Revenue Growth

-66.70%

7.80%

Earnings Growth

-96.10%

61.40%

Price & Risk

Beta

1.1

0.3

52-Week High

$34.68

$507.92

52-Week Low

$10.71

$362.50

Analyst Target

$39.04

$548.69

Compare ROIV and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.